Prognostic and Immunotherapeutic Role of TACC3 in Pancancer and Its Impact on Proliferation and Docetaxel Resistance in Lung Adenocarcinoma
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Transforming acidic coiled-coil containing protein 3 (TACC3) is highly expressed in cancers, linked to poor prognosis, and predicts immunotherapy response. TACC3 also shows potential in overcoming docetaxel resistance, particularly in lung adenocarcinoma.
Area Of Science
- Oncology
- Molecular Biology
- Immunology
Background
- Transforming acidic coiled-coil containing protein 3 (TACC3) plays a key role in cancer progression, cell division, and tumor growth.
- Limited research exists on the pancancer implications of TACC3.
- This study investigates TACC3's pancancer role and validates findings in lung adenocarcinoma.
Purpose Of The Study
- To analyze the expression and prognostic significance of TACC3 across various cancer types.
- To explore the relationship between TACC3 and immune infiltration, immune checkpoints, and immunotherapy response.
- To investigate TACC3's role in drug sensitivity, specifically docetaxel resistance, and validate in lung adenocarcinoma.
Main Methods
- Bioinformatic analysis of TACC3 expression, prognosis, and immune correlations in pancancer datasets.
- Analysis of TACC3's association with immune infiltration and immunotherapy response prediction.
- In vitro experimental validation of TACC3's role in lung adenocarcinoma proliferation and docetaxel resistance.
Main Results
- TACC3 is highly expressed in human cancers, correlating with poor prognosis.
- TACC3 is implicated in immune infiltration and shows predictive value for immunotherapy response.
- A link between TACC3 and docetaxel resistance was identified and validated in lung adenocarcinoma.
Conclusions
- TACC3 is a potential therapeutic target for overcoming immunosuppression in pancancer.
- TACC3 may serve as a predictive biomarker for docetaxel resistance, especially in lung adenocarcinoma.
- Further research into TACC3's role in cancer progression and treatment is warranted.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...